• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov13
Sellas Life Sciences released FY2025 9 Months Earnings on November 12 EST, with actual revenue of USD 0 and EPS of USD -0.1362
04:00
Sellas Life Sciences released FY2025 Q3 earnings on November 12 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.0626 (forecast USD -0.0766)
04:00
Aug13
Sellas Life Sciences released FY2025 Semi-Annual Earnings on August 12 (EST) with actual revenue of USD 0 and EPS of USD -0.1332
03:00
Sellas Life Sciences released FY2025 Q2 earnings on August 12 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.07 (forecast USD -0.0766)
03:00
Jul15
SELLAS Life Sciences Group's SLS009 Phase 2 Trial Meets All Primary Endpoints in AML
11:46
Jul7
SELLAS Life Sciences Group Adds New Executive
13:52

Schedules & Filings

Schedules
Filings
Nov12
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -6.791 M, EPS -0.0626

Aug12
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -6.601 M, EPS -0.07

May13
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -5.813 M, EPS -0.0662

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
MSOX
7.940
+107.85%
+4.120
YCBD
1.200
+90.17%
+0.569
THH
15.520
+57.72%
+5.680
WEED
25.325
+55.65%
+9.055
NCI
1.920
+54.84%
+0.680
CNBS
34.820
+54.57%
+12.293
MSOS
5.800
+54.26%
+2.040
CGC
1.740
+53.98%
+0.610
RYM
23.800
+47.73%
+7.690
TLRY
12.150
+44.13%
+3.720
View More